Author:
Tan She Hui,Goh Louise Gek Huang,Ong Benjamin Shao Kiat,Ng Darren Sze Guan,Lin Liang,Ng Raymond Chee Hui,Thong Bernard Yu-Hor,Ng Kwong
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. OECD and World Health Organization. Health at a Glance: Asia/Pacific 2016.
2. Fitch Solutions Group. Singapore Pharmaceuticals & Healthcare report Q3 2022. 2022
3. Singapore—Country Commercial Guide. Healthcare, Opportunities. 2022. 11 August 2022 to 18 October 2023. https://safe.menlosecurity.com/https://www.trade.gov/country-commercial-guides/singapore-healthcare. Accessed 2 June 2023.
4. Halimi V, et al. Clinical and regulatory concerns of biosimilars: a review of literature. Int J Environ Res Public Health. 2020;17(16):5800.
5. Gherghescu I, Delgado-Charro MB. The biosimilar landscape: an overview of regulatory approvals by the EMA and FDA. Pharmaceutics. 2020;13(1):48.